The average 12-month price target on the company stock within the last year is $60.67, according to the report. The company has a one-year high of $62.83 and a one-year low of $40.
More articles on transactions and valuation issues:
AmSurg CAO sells nearly 9k shares
5 recent ASC company acquisitions & partnerships
Park Hill – MOB and ASC open in Fort Worth: 8 key points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.